Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-21

Clinical Trial Update: Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial comparing memantine versus bupropion for smoking relapse in nicotine-dependent individuals; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Namenda (memantine)
  • Wellbutrin (bupropion)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Tobacco Use Disorder | Phase 1 | Status: COMPLETED